Understanding the investment opportunity
VRAIn is a Digital Health startup founded in 2020 and based in Barcelona. The company develops cutting-edge software solutions for the medical sector.
Its technology is a cloud platform for the visualization and automated analysis of biomedical images (DICOMs). This technology combines Virtual Reality (VR), Artificial Intelligence (AI) and Cloud processing to create an immersive and multidimensional spatial computing environment.
VRAIn's first product on the market is AthleteVR, a Software as a Service (SaaS) tool for medical diagnosis support, focused on Traumatology and Sports Medicine and aimed at private clinics in the sector and professional sports clubs.
AthleteVR highlights subtle details of the musculoskeletal system and its soft tissues that are ambiguous with conventional techniques.
AthleteVR transforms any complex musculoskeletal Magnetic Resonance Imaging (MRI) or Computerized Tomography (CT) scan into an Immersive Digital Twin (IDT), a supremely intuitive and accurate visualization of the anatomical condition in question.
It aims and succeeds at avoiding many unnecessary surgeries, prioritizing non-surgical and less invasive treatments.
For the doctor, it represents a paradigm shift: moving from "just looking at" scans to capturing their entire true meaning.
For the patient, it means avoiding unnecessary surgeries and moving from being a passive spectator of their pathology to following medical explanations and actively participating in their own recovery.
Musculoskeletal (MSK) conditions are a massive health problem, affecting 50% of the adult population, accounting for 40% of primary care visits, and are increasing due to population aging. (Sources: National Library of Medicine, Evernorth Health Services, Frontiers, Family Medicine).
Currently, ambiguity in conventional medical imaging and 3D models causes clinical uncertainty. This lack of clarity, especially in the diagnosis of soft tissues (muscles, tendons, ligaments, and menisci), can lead to unnecessary surgeries or surgeries with incomplete information, which entails health risks and associated costs that are unmanageable for most healthcare systems.
In professional sports, this ambiguity translates directly into lost competitions for clubs, compromised sports careers for players, and the devaluation of their transfer value.
The company aspires to turn its product into the new gold standard of healthcare in musculoskeletal medical care. AthleteVR seeks to be the essential prerequisite step before any trauma surgery, ensuring that preventive or less invasive treatments are alternatively considered, thus avoiding unnecessary interventions.
Currently, VRAIn already has recurring revenue from two private sports medicine clinics, with a third in the contracting process.
Furthermore, the startup has a paid pilot agreement with a leading pharmaceutical company, as well as ongoing discussions with top-tier sports clubs and competitions, including MotoGP, the Toronto Raptors (NBA), one of the most prominent First Division football clubs, and Hiopos Bàsquet Club (ACB).
IMPORTANT NOTICE
Investors who complete their investment by signing the subscription agreement by 25 January 2026 (inclusive) will receive a 10% bonus on equity. Once the funding round closes, the equity allocation corresponding to the invested amount will be calculated, and the company will top up an additional 10% of shares at no extra cost.
Furthermore, exclusively during this initial phase, confirmed investors will have access to their own Digital Immersive Twin (DIT), allowing them to experience the company’s technology firsthand. VRAIn Medical will deliver an immersive video generated from the investor’s medical imaging, following this process:
- Processing the images with our proprietary technology to create a multidimensional, highly accurate, and data-rich replica of the anatomy (DIT).
- Exploring the model from multiple perspectives, both internal and external, within an immersive Virtual Reality (VR) environment.
- Capturing the experience in an MP4 video, narrated by the company’s medical team.
Investors completing their investment by signing the subscription agreement between 26 January 2026 and 8 February 2026 (inclusive) will receive a 6% equity bonus, applied once the round closes, under the same terms outlined above.
INVESTMENT STAGE
MARKET
- virtual-reality
- biotech
- software-development
- (+2)
OFFICIAL WEBPAGE
Fiscal benefits
VRAIn Medical Team
CEO
Daniel Esteban-Ferrer
CEO
CIO
Jordi Carbó
CIO
COO
Azucena Rodríguez
COO
Pau Serra
Medical Lead
ESADE BAN
BUSINESSANGEL
Economistes BAN
INVESTOR
Felix González
BUSINESSANGEL
Barcelona Activa
INCUBATOR
Lanzadera
ACCELERATOR
Wayra
ACCELERATOR
Reasons to invest View more data
Market Opportunity
- The Musculoskeletal (MSK) health problem is massive and growing, impacting global health systems and elite sports. VRAIn operates in a large and high-growth niche with direct competition still incipient. This is a blue ocean where the company can navigate thanks to its technological innovation, something its competitors are not yet doing.
Product and Traction
AthleteVR is the solution. The MVP is already on the market generating revenue and is currently being used as a patient engagement tool (by one of the leading pharmaceutical companies at a national level). It has attracted the interest of top-tier teams, including MotoGP and one of the main First Division football clubs. With medical regulatory approval expected by the end of 2026, it will become a diagnostic support tool.
Technology and Competitive Advantage
- The underlying technology is the result of five years of in-house development with a common, robust, and versatile software architecture. Its modular design allows for agile and flexible adaptation to specific market needs (go-to-market), ensuring a sustainable advantage that the company will patent with the financing from this investment round.
Intellectual Property
- VRAIn has a clear roadmap to protect its innovation. The international patent registration for the next version of AthleteVR is planned for January 2026 and will cover the European and US markets.
Human Capital
- The main competitive advantage is the team, which combines deep knowledge in disruptive technologies (VR, AI, The Cloud) with expertise in the Health and Sports sectors, combining IT and business profiles. The team has been recognized by national and European institutions, and has invested their personal capital in VRAIn, which demonstrates their total commitment.
Business Model and Scalability
- AthleteVR's SaaS model is highly scalable by definition. The go-to-market strategy is already proven, with recurring revenue from two private clinics (Elit Medicine and Kroton). The agreement with a major pharmaceutical company provides access to more than 500 musculoskeletal clinics only in Spain, and direct discussions with Key Opinion Leaders (KOLs) in organizations such as the Toronto Raptors and MotoGP open direct channels for business and validation
Objectives
- Objectives for the coming years are directed towards international expansion, obtaining intellectual property, and regulatory certification. VRAIn only needs the strategic investment to unlock its potential and execute the defined roadmap.
Proven, Reliable, and Scalable Marketing Strategy
- Growth Marketing Strategy and free trial of the AthleteVR platform: The combination of both attracts a large user base and generates a powerful funnel for capturing users interested in the Basic, Advanced, or Elite paid subscription services.
- KOL Strategy in Health and Sports: The pilot study with a major pharmaceutical company and, likely, the future agreement with one of the world’s top football clubs provides AtheleVR with credible and immediate access to hundreds of client clinics and clubs, drastically reducing its Customer Acquisition Cost (CAC) and shortening its sales cycle.
Who is the reference investor?
ESADE BAN
STARTUP
About ESADE BAN
ESADE BAN es una red de inversores privados promovida por el Club Emprendedores e Inversores ESADE Alumni y tiene por objetivo dinamizar la actividad emprendedora e inversora en España. Para ello, se propone hacer crecer el tejido financiero de nuestro país reclutando, educando y coordinando la que queremos que sea la mayor red de inversores privados (business angels) del país por número de operaciones. ESADE BAN está focalizada sobre todo en el impulso de empresas de nueva creación o en las primeras fases de crecimiento. El modelo preferido de inversión de los asociados de nuestra red es la co-inversión con otros miembros de la red o con empresas de capital riesgo.- Investing in startups: Since 2008
- Euros invested: €48M
- Investments:317
- EXITS:20%
Fernando Zallo (Director of ESADE BAN):
"We saw a very remarkable technology and team in VRAIn from the beginning, which is why we invited them to the Barcelona forums, the Madrid forums, and the DeepTech forum we organized with the best universities. At ESADE BAN, we are very selective, and the fact that VRAIn has managed to raise €65k is a very important milestone and gives recognition to their great work. We believe the EXIT will be very profitable."
Dr. Ramon Ciurana (Lead Investor of ESADE BAN):
"As a medical professional, I was already decided to invest in VRAIn since their initial presentation. However, any residual doubts were immediately dispelled upon observing their functionalities and extraordinary potential firsthand.
While three-dimensional reconstruction from CT or MRI images is not an innovation in itself, the ability to interact with these images using virtual reality allows one to surf through anatomical structures, permitting travel inside a bone, a blood vessel, or a lung. This level of exploration is not only an unprecedented experience for the healthcare professional but also for the patient.
Medical practice fundamentally rests on trust between doctor and patient. In this sense, when the patient can visualize their own pathology—be it a fracture, an injury, or an atheroma plaque in an artery—and understand it directly and see the evolution of their process, trust and security are exponentially enhanced. This strengthens the therapeutic relationship and encourages more informed decision-making."
It has also invested in...
Live
Chat
You need to be registered to view the content
This content is confidential and you must be registered with Startupxplore in order to access it.
Register meOpportunity analysis Last update Jan 12, 2026 12:05:01 PM
You need to be registered to view the content
This content is confidential and you must be registered with Startupxplore in order to access it.
Register meInvestor questions
The regulations governing Startupxplore's activity require that no investor is in possession of more information than the rest. Therefore, this section will provide answers to any questions asked by an investor about the opportunity.
If you have any doubts or questions about the startup, the process or any other aspect please write to us at coinversion@startupxplore.com
You need to be registered to view the content
This content is confidential and you must be registered with Startupxplore in order to access it.
Register meDocumentation
You need to be registered to view the content
This content is confidential and you must be registered with Startupxplore in order to access it.
Register me